Search

Your search keyword '"Maggi L"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Maggi L" Remove constraint Author: "Maggi L" Topic business.industry Remove constraint Topic: business.industry
41 results on '"Maggi L"'

Search Results

1. Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study

2. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

3. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

4. Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

5. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab:subgroup analysis of REGAIN and its extension study

6. A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis

7. Eculizumab Improves Fatigue in Refractory Generalized Myasthenia Gravis

8. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

9. LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population

10. Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients

11. The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients

12. A Randomized Trial of the Impact of Certified Mail on Response Rate to a Physician Survey, and a Cost-Effectiveness Analysis

13. Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis

14. Weekly low-dose paclitaxel as maintenance treatment in patients with advanced ovarian cancer who had microscopic residual disease at second-look surgery after 6 cycles of paclitaxel/platinum-based chemotherapy: results of an open non comparative phase 2 multicenter Italian study (After-6 Protocol 2)

15. Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders

16. Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients

17. Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease

18. Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis

19. SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19 ward of a hospital in Milan, Italy

20. Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients

21. Large genotype–phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis

22. Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3

23. Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes

24. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

25. A novel PNPLA2 mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathy

26. Therapeutic efficacy of 3,4-Diaminopyridine phosphate on neuromuscular junction in Pompe disease

27. Cytokine Profile in Striated Muscle Laminopathies: New Promising Biomarkers for Disease Prediction

28. Glycogen storage in a zebrafish Pompe disease model is reduced by 3-BrPA treatment

29. Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients

30. P3170Innovative approach for risk stratification of LMNA-related cardiomyopathy: results from an integrated cardiological and neurological 10-year follow-up multicentre study

31. Propofol sedation reduces diaphragm activity in spontaneously breathing patients: ultrasound assessment

32. Biobank of Cells, Tissues and DNA from Patients with Neuromuscular Diseases: An Indispensable link between Clinical Centers and the Scientific Community

33. Cardiac and Neuromuscular Features of Patients WithLMNA-Related Cardiomyopathy

34. The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients

35. Anti-fibrotic effect of pirfenidone in muscle derived-fibroblasts from Duchenne muscular dystrophy patients

36. Muscle MRI findings in facioscapulohumeral muscular dystrophy

37. Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohort

38. LMNA-associated myopathies: the Italian experience in a large cohort of patients

39. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis

40. Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression

41. MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients

Catalog

Books, media, physical & digital resources